Friday, May 19, 2023 7:15:48 PM
Shionogi is in a PH III trial with their 3CL Pro Inhib that hopefully is as effective as Pax and without the other issues--but that will be months+ for trial results and possible FDA approve/EUA
The TolloVID is NOT approved to treat covid but it doesn't need EUA because it is a OTC version of 3CL Pro Inhibitor. Todos drug version TolloVIR had great results in a PH II trial in Israel (it was small size) but never had funds to run PH III--which is sad from several ways. They did not receive a EUA either in Israel for TolloVIR which easily could have saved some lives but anecdotal until allowed.
As far as Todos they are 1st to state "not approved to diagnose, treat, prevent or cure ANY disease"--only states 3CL Protease Inhibitor that FDA agrees. But we see Drs that are using for Viral eradication--and writing about TolloVID and talking about its use with patients
There have been people that posted here and DR Dorit Arad has talked about using Tollovid in acute covid but they have learned not to make ANY claims about covid
Recent TOMDF News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 07/17/2023 12:29:32 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM